Literature DB >> 3839666

Vitreolysis with the Q-switched laser.

F Fankhauser, S Kwasniewska, E van der Zypen.   

Abstract

We present an overview concerning the current status of photodisruptive methods used in the treatment of pathologic changes in the vitreous space. In one series of 320 cases studied, 65% of the planned dissections of pathologic structures were successful. In a second series of 34 more complicated cases, the success rate was even lower. Complications included 15 retinochoroidal hemorrhages and one damaged posterior lens capsule. When one compares optical-surgical methods with conventional methods, it is obvious that the former aim at achieving goals that are less ambitious than those of classic vitrectomy and, in many cases, serve only to prepare for - and facilitate - a classic vitrectomy. By definition, laser vitreolysis dissects, but cannot remove, the fragments of disrupted structures from the eyeball. However, despite the obvious risks, photodisruptive laser surgery is considered less dangerous than is classic vitrectomy because photodisruption is a "noninvasive" procedure. Since laser vitreolysis is able to solve a number of clinical problems, obviating the need for vitrectomy, the former procedure should receive increasing attention for the treatment of pathologic problems in the vitreous cavity.

Entities:  

Mesh:

Year:  1985        PMID: 3839666     DOI: 10.1001/archopht.1985.01050080078025

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  10 in total

1.  Reported Complications Following Laser Vitreolysis.

Authors:  Paul Hahn; Eric W Schneider; Homayoun Tabandeh; Robert W Wong; Geoffrey G Emerson
Journal:  JAMA Ophthalmol       Date:  2017-09-01       Impact factor: 7.389

2.  Nd:YAG laser photodisruption: an experimental investigation on shielding and multiple plasma formation.

Authors:  M R Capon; F Docchio; J Mellerio
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

3.  Treatment of vitreous floaters with neodymium YAG laser.

Authors:  W F Tsai; Y C Chen; C Y Su
Journal:  Br J Ophthalmol       Date:  1993-08       Impact factor: 4.638

4.  Q-switched neodymium YAG laser vitreolysis in the therapy of posterior segment disease.

Authors:  J D Jagger; A M Hamilton; P Polkinghorne
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

Review 5.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

Review 6.  Vitrectomy for primary symptomatic vitreous opacities: an evidence-based review.

Authors:  T Ivanova; A Jalil; Y Antoniou; P N Bishop; J L Vallejo-Garcia; N Patton
Journal:  Eye (Lond)       Date:  2016-03-04       Impact factor: 3.775

7.  [Vitreous body floaters and vitrectomy with full visual acuity].

Authors:  H Hoerauf; M Müller; H Laqua
Journal:  Ophthalmologe       Date:  2003-06-18       Impact factor: 1.059

8.  Rapid Cataract Progression after Nd:YAG Vitreolysis for Vitreous Floaters: A Case Report and Literature Review.

Authors:  I-Ting Sun; Tsung-Han Lee; Chih-Hsin Chen
Journal:  Case Rep Ophthalmol       Date:  2017-05-29

9.  Management of Macular Pre-Retinal Subhyaloid hemorrhage by Nd:Yag laser hyaloidotomy.

Authors:  Faisal Murtaza; Syed Fawad Rizvi; Syeda Aisha Bokhari; Zeeshan Kamil
Journal:  Pak J Med Sci       Date:  2014-03       Impact factor: 1.088

Review 10.  Safety and Efficacy of YAG Laser Vitreolysis for the Treatment of Vitreous Floaters: An Overview.

Authors:  Andreas Katsanos; Nikoleta Tsaldari; Konstantina Gorgoli; Fotios Lalos; Maria Stefaniotou; Ioannis Asproudis
Journal:  Adv Ther       Date:  2020-02-21       Impact factor: 3.845

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.